- Report
- December 2024
- 150 Pages
Global
From €2896EUR$3,250USD£2,512GBP
€4322EUR$4,850USD£3,748GBP
- Report
- April 2025
- 43 Pages
Global
From €1069EUR$1,200USD£927GBP
- Report
- January 2025
- 77 Pages
Global
From €3500EUR$4,208USD£3,142GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,208USD£3,142GBP
- Report
- August 2024
- 140 Pages
Global
From €2816EUR$3,160USD£2,442GBP
€3520EUR$3,950USD£3,053GBP
- Report
- June 2025
- 400 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- June 2025
- 400 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- June 2025
- 400 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- June 2025
- 400 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- August 2024
- 200 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- December 2024
- 150 Pages
Global
From €3520EUR$3,950USD£3,053GBP
- Report
- May 2025
- 220 Pages
Global
From €4451EUR$4,995USD£3,860GBP
- Report
- April 2025
- 179 Pages
Global
From €4451EUR$4,995USD£3,860GBP
- Report
- January 2025
- 50 Pages
Global
From €2227EUR$2,499USD£1,931GBP
- Report
- December 2024
- 55 Pages
Global
From €2227EUR$2,499USD£1,931GBP
- Report
- April 2025
- 220 Pages
Global
From €1780EUR$1,997USD£1,543GBP
- Newsletter
- July 2025
Global
€2669EUR$2,995USD£2,315GBP
- Report
- June 2025
- 193 Pages
Global
From €4411EUR$4,950USD£3,826GBP
- Report
- June 2025
- 105 Pages
Global
From €3074EUR$3,450USD£2,666GBP
- Report
- June 2025
- 180 Pages
Global
From €2495EUR$2,800USD£2,164GBP
€3564EUR$4,000USD£3,091GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more